HuGE Literature Finder
|
||
Records 1-12
|
Metabolic control, ApoE genotypes, and dyslipidemia in children, adolescents and young adults with type 1 diabetes.
Atherosclerosis 2018 Apr 273 53-58. Macedoni Maddalena, Hovnik Tinka, Plesnik Emil, Kotnik Primoz, Bratina Natasa, Battelino Tadej, Groselj U |
|
LPA kringle IV type 2 is associated with type 2 diabetes in a Chinese population with very high cardiovascular risk.
Journal of lipid research 2018 Mar . Mu-Han-Ha-Li Di-Li-Da-Er, Zhai Tian-Yu, Ling Yan, Gao X |
|
Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2016 Feb . Kronenberg Flori |
|
Low "quotient" Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2015 Jan 123 (1): 11-8. Onat A, Çoban N, Can G, Yüksel M, Karagöz A, Yüksel H, Ademo?lu E, Erginel-Ünaltuna |
|
The association between circulating lipoprotein(a) and type 2 diabetes: is it causal?
Diabetes 2014 Jan 63 (1): 332-42. Ye Zheng, Haycock Philip C, Gurdasani Deepti, Pomilla Cristina, Boekholdt S Matthijs, Tsimikas Sotirios, Khaw Kay-Tee, Wareham Nicholas J, Sandhu Manjinder S, Forouhi Nita |
|
Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study.
The lancet. Diabetes & endocrinology 2013 Nov 1 (3): 220-7. Kamstrup Pia R, Nordestgaard Børge |
|
Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatment.
Pharmacogenetics and genomics 2013 Jul . Donnelly LA, van Zuydam NR, Zhou K, Tavendale R, Carr F, Maitland-van der Zee AH, Leusink M, de Boer A, Doevendans PA, Asselbergs FW, Morris AD, Pearson ER, Klungel OH, Doney AS, Palmer CN |
Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a).
Journal of lipid research 2012 May 53 (5): 1000-11. Deshmukh Harshal A, Colhoun Helen M, Johnson Toby, McKeigue Paul M, Betteridge D John, Durrington Paul N, Fuller John H, Livingstone Shona, Charlton-Menys Valentine, Neil Andrew, Poulter Neil, Sever Peter, Shields Denis C, Stanton Alice V, Chatterjee Aurobindo, Hyde Craig, Calle Roberto A, Demicco David A, Trompet Stella, Postmus Iris, Ford Ian, Jukema J Wouter, Caulfield Mark, Hitman Graham A, |
|
Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.
European heart journal 2012 Feb 33 (3): 325-34. Qi Qibin, Workalemahu Tsegaselassie, Zhang Cuilin, Hu Frank B, Qi |
|
Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients.
Frontiers in immunology 2012 3 367. Egaña-Gorroño Lander, Martínez Esteban, Escribà Tuixent, Calvo Marta, Gatell José M, Arnedo Mire |
|
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Diabetes care 2010 Oct 33 (10): 2250-3. Bailey Swneke D, Xie Changchun, Do Ron, Montpetit Alexandre, Diaz Rafael, Mohan Viswanathan, Keavney Bernard, Yusuf Salim, Gerstein Hertzel C, Engert James C, Anand Sonia, |
|
Phenotype-genotype interactions on renal function in type 2 diabetes: an analysis using structural equation modelling.
Diabetologia 2009 Aug 52 (8): 1543-53. Song X Y, Lee S Y, Ma R C W, So W Y, Cai J H, Tam C, Lam V, Ying W, Ng M C Y, Chan J C |
- Page last reviewed:Jul 30, 2019
- Page last updated:Nov 21, 2019
- Content source: